Publication | Open Access

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

Overall SurvivalGastrointestinal OncologyMedicineRandomised Phase 3Biliary CancerPathologyCancer TreatmentOncologyRadiation OncologyCancer Research